top of page
Report Summary
Market Overview

Global Clinical Diagnostics Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)

Global Clinical Diagnostics Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)


Market Segmentation: By Test (Lipid Panel, Liver Panel, Renal Panel, Complete Blood Count, Electrolyte Testing, Infectious Disease Testing, and Other Tests), Product (Instruments, Reagents, and Other Products), End User (Hospital Laboratory, Diagnostic Laboratory, Point-of-care Testing, and Other End Users), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)


Market Overview


The Global Clinical Diagnostics Market was valued at USD 80,839.1 million in 2023 and is expected to reach USD 129,820.8 million by 2031 while growing at a CAGR of 6.1% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Market Dynamics


This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global clinical diagnostics market growth. Clinical diagnostics, the process of identifying diseases, conditions, or pathogens in patients through signs, symptoms, and laboratory test results, plays a vital role in healthcare. It facilitates accurate disease diagnosis, prognosis, treatment selection, and monitoring patients' responses to therapy.


The clinical diagnostics market is growing due to rising chronic and infectious diseases and advancements in diagnostic technologies like molecular diagnostics, immunoassays, point-of-care testing, and high-throughput screening platforms. Yet, regulatory challenges and cost constraints could hinder its expansion.


Furthermore, the global clinical diagnostics industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.


Segmentation – By Test Analysis


The Global Clinical Diagnostics Market is segmented among Lipid Panel, Liver Panel, Renal Panel, Complete Blood Count, Electrolyte Testing, Infectious Disease Testing, and Other Tests, based on Test. In 2023, Lipid Panel accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Segmentation – By Product Analysis


The Global Clinical Diagnostics Market is segmented among Instruments, Reagents, and Other Products, based on Product. In 2023, Instruments accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Global Clinical Diagnostics Market: Regional Analysis


Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Competitive Landscape


Some of the key players operating in the market are Abbott Laboratories, Becton, Dickinson and Company, BioMerieux, Bio-Rad Laboratories Inc., Danaher Corporation, Siemens AG, Hologic Inc., Qiagen NV, F. Hoffmann-La Roche AG, and Thermo Fisher Scientific.


Table of Contents:


1. Research Methodology and Market Scope

  • Research Methodology

  • Market Scope

2. Executive Summary

3. Global Clinical Diagnostics Market Dynamics

  • Drivers

  • Restraints

  • Opportunity

4. Global Clinical Diagnostics Industry Analysis

  • PEST Analysis

  • Porter's Five Force Analysis

  • Recent Deals Analysis

5. Global Clinical Diagnostics Market Segmentation, By Test

  • Global Clinical Diagnostics Market Share Analysis, By Test

  • Global Clinical Diagnostics Market Growth Analysis, By Test

  • Global Clinical Diagnostics Market Trends, By Test

o Lipid Panel

o Liver Panel

o Renal Panel

o Complete Blood Count

o Electrolyte Testing

o Infectious Disease Testing

o Other Tests

6. Global Clinical Diagnostics Market Segmentation, By Product

  • Global Clinical Diagnostics Market Share Analysis, By Product

  • Global Clinical Diagnostics Market Growth Analysis, By Product

  • Global Clinical Diagnostics Market Trends, By Product

o Instruments

o Reagents

o Other Products

7. Global Clinical Diagnostics Market Segmentation, By End User

  • Global Clinical Diagnostics Market Share Analysis, By End User

  • Global Clinical Diagnostics Market Growth Analysis, By End User

  • Global Clinical Diagnostics Market Trends, By End User

o Hospital Laboratory

o Diagnostic Laboratory

o Point-of-care Testing

o Other End Users

8. Global Clinical Diagnostics Market Segmentation, By Region

  • Global Clinical Diagnostics Market Share Analysis, By Region

  • Global Clinical Diagnostics Market Growth Analysis, By Region

  • Global Clinical Diagnostics Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

9. Competitive Landscape

  • Abbott Laboratories*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

  • Becton, Dickinson and Company

  • BioMerieux

  • Bio-Rad Laboratories Inc.

  • Danaher Corporation

  • Siemens AG

  • Hologic Inc.

  • Qiagen NV

  • F. Hoffmann-La Roche AG

  • Thermo Fisher Scientific

*Similar analysis will be provided for each company listed above.

REPORT.png
Pricing Plan
Segmentation
Regional Analysis
Table of Contents
bottom of page